Tag: NeuroRelease
InVivo Therapeutics clashes with PixarBio over proposed takeover
Invivo Therapeutics has rebuked a press release from PixarBio claiming that it had made a US$77,000,000 stock offer to acquire the company.
The colourfully-worded release,...
PixarBio establishes research centre focusing on spinal cord injury treatment
PixarBio—developers of NeuroRelease, a morphine replacement, non-opioid pain treatment—has established the JP Reynolds Research Center in Woburn, USA.
The lab will focus on research and...
